Breakthrough in Regenerative Medicine: Exclusively activates STAT-ERK signaling pathway to directly boost hepatocyte proliferation and regeneration
Multi-target Comprehensive Intervention: Exerts four effects including antioxidation, anti-inflammation, cell death inhibiti on and regeneration promotion
40-year Safe Application History: Completed clinical trials in Japan and South Korea; marketed in four countries including South Korea and Mongolia
Absolute Biosafety: Three rounds of virus detection and validated inactivation process ensure zero safety risks
Official Authorization: The only product among six similar South Korean products passing regulatory clinical re-evaluation
—— Turkish Supintro™ TGGP Bone Gel Cartilage Repair Fluid
Product Positioning
A biological agent that fundamentally improves liver function via hepatocyte regeneration mechanism. LANNENC is centered on 15 amino acids and active peptides extracted from hydrolyzed human placenta. It breaks the limitation of conventional liver drugs that only protect the liver and reduce enzymes, targeting the root cause of liver damage repair.
Core Advantages
Product Indications
Liver function improvement for chronic liver diseases
Clinical Value
After 4 weeks of treatment:
62.9% of patients achieved significant ALT improvement (decline ≥20%)
ALT levels dropped to safe ranges in 54.3% of severe patients (p=0.02)
